Webinar: Ask a VC (2023)

Do you have a burning question on venture capital you need answered? Join OUP for our fourth annual ‘Ask a VC’ webinar, a session where our partner TTOs can ask Managing Partners Marc Singer and Bill Harrington anything and everything as it pertains to venture capital operations, decision-making, and the current investing environment. Since the…

Webinar: Equity Compensation in University Startups

Equity compensation can be an opaque and awkward topic for first-time academic founders. Join us for a webinar that is an in-depth look at venture capital perspectives on the economics of university startup formation, particularly founders’ equity. OUP will review an analysis of the equity structures of over 90 startups combined with our collective insights…

Webinar: Equity Liquidation After IPO Analysis

A common practice across universities that hold equity in a company that IPOs is to sell all of its shares as soon as the lock up expires. But do the best returns necessarily come from selling all your stock immediately? When is the right time to sell stock in a therapeutics company?

Webinar: 2019 Midyear Financing Trends

It’s Spring, which means it is once again time for OUP’s annual financing trends webinar. Which sectors have had the greatest amounts of investment and which are facing funding challenges? How do these trends apply to advancing academic technologies? What does the beginning of 2019 imply for the rest of the year and what lies over the horizon?

Webinar: The Open-Source Business Model for University Software Startups

Academics looking to maximize the impact of their research shouldn’t consider commercialization a Faustian bargain, trading open publication and monetary returns. Open-source software can be a successful strategy towards both impact and income.

Join David Dorsey and John Lee of Osage University Partners as they discuss why open source provides substantial advantages for software startups and why it has become the de facto method for deploying and commercializing software.

Webinar: Small Molecule vs Antibody Development Challenges

Therapeutics remain the primary focus for life science venture investments. As we all know, pre-clinical development of therapeutics is complicated, time consuming, and capital intensive. In the early stages of development, multiple aspects of a therapeutic product need to be optimized to enhance its drug-like properties. However, given the limited time and resources in the academic setting, what aspects of development should inventors focus on? Before diving into drug development, inventors should ask themselves: What is feasible in an academic setting? What is valued more by the investors? Should it be performed in-house or be out-sourced? How much would it cost?

Webinar: Venture Capital & University Startup Financial Trends of 2018

We’re almost halfway through 2018, which means it is once again time for OUP’s annual financing trends webinar. Which sectors have had the greatest investment and which are facing funding challenges? How do these trends apply to advancing academic technologies? What does the beginning of 2018 imply for the rest of the year and what lies over the horizon?